{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:18:31Z","timestamp":1764937111450,"version":"build-2065373602"},"reference-count":62,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ackdjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1053\/j.ackd.2019.08.013","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T23:13:18Z","timestamp":1573686798000},"page":"330-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Pregnancy in Women With Systemic Lupus and Lupus Nephritis"],"prefix":"10.1053","volume":"26","author":[{"given":"Sharon","family":"Maynard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6862-9775","authenticated-orcid":false,"given":"Grace","family":"Guerrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1053\/j.ackd.2019.08.013_bib1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/0961203308097575","article-title":"Maternal and foetal outcomes in pregnant patients with active lupus nephritis","volume":"18","author":"Wagner","year":"2009","journal-title":"Lupus"},{"issue":"9","key":"10.1053\/j.ackd.2019.08.013_bib2","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3899\/jrheum.100997","article-title":"Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis","volume":"38","author":"Bramham","year":"2011","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1053\/j.ackd.2019.08.013_bib3","first-page":"1526","article-title":"Clinical predictors of fetal outcome in systemic lupus erythematosus","volume":"25","author":"Rahman","year":"1998","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1053\/j.ackd.2019.08.013_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M14-2235","article-title":"Predictors of pregnancy outcomes in patients with lupus: a cohort study","volume":"163","author":"Buyon","year":"2015","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1053\/j.ackd.2019.08.013_bib5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1080\/01443610400007836","article-title":"Pregnancy outcome in women with pre-existing lupus nephritis","volume":"24","author":"Soubassi","year":"2004","journal-title":"J Obstet Gynaecol"},{"issue":"3","key":"10.1053\/j.ackd.2019.08.013_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ni1037","article-title":"Regulatory T cells mediate maternal tolerance to the fetus","volume":"5","author":"Aluvihare","year":"2004","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1053\/j.ackd.2019.08.013_bib7","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/1471-0528.15042","article-title":"Angiogenic factors: potential to change clinical practice in pre-eclampsia?","volume":"125","author":"Cerdeira","year":"2018","journal-title":"BJOG"},{"issue":"1","key":"10.1053\/j.ackd.2019.08.013_bib8","doi-asserted-by":"crossref","first-page":"108.e1","DOI":"10.1016\/j.ajog.2015.09.066","article-title":"Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study","volume":"214","author":"Kim","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1053\/j.ackd.2019.08.013_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1365-2249.1999.00997.x","article-title":"Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia","volume":"117","author":"Saito","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1053\/j.ackd.2019.08.013_bib10","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.4049\/jimmunol.174.12.7692","article-title":"Genetic determination of T cell help in loss of tolerance to nuclear antigens","volume":"174","author":"Chen","year":"2005","journal-title":"J Immunol"},{"issue":"3","key":"10.1053\/j.ackd.2019.08.013_bib11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2249.1990.tb03311.x","article-title":"Oestrogen is a potent disease accelerator in SLE-prone MRL lpr\/lpr mice","volume":"80","author":"Carlsten","year":"1990","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1053\/j.ackd.2019.08.013_bib12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/ndt\/gfn348","article-title":"Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome","volume":"24","author":"Imbasciati","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2019.08.013_bib13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1600-0897.2005.00263.x","article-title":"Class III-IV proliferative lupus nephritis and pregnancy: a study of 42 cases","volume":"53","author":"Carmona","year":"2005","journal-title":"Am J Reprod Immunol"},{"issue":"9","key":"10.1053\/j.ackd.2019.08.013_bib14","first-page":"1709","article-title":"Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period","volume":"32","author":"Clark","year":"2005","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1053\/j.ackd.2019.08.013_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11926-003-0021-9","article-title":"New insights into pregnancy-related complications in systemic lupus erythematosus","volume":"5","author":"Erkan","year":"2003","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"10.1053\/j.ackd.2019.08.013_bib16","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2215\/CJN.00240110","article-title":"A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis","volume":"5","author":"Smyth","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2019.08.013_bib17","doi-asserted-by":"crossref","first-page":"2413637","DOI":"10.1155\/2018\/2413637","article-title":"Fetal and maternal outcomes of planned pregnancy in patients with systemic lupus erythematosus: a retrospective multicenter study","volume":"2018","author":"Chen","year":"2018","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1053\/j.ackd.2019.08.013_bib18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1053\/j.ackd.2019.08.013_bib19","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1517\/14656566.2015.1031654","article-title":"Preserving fertility when choosing chemotherapy regimens\u2014the role of gonadotropin-releasing hormone agonists","volume":"16","author":"Blumenfeld","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"10.1053\/j.ackd.2019.08.013_bib20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.semarthrit.2011.05.008","article-title":"Gonadotropin releasing hormone agonists may minimize cyclophosphamide associated gonadotoxicity in SLE and autoimmune diseases","volume":"41","author":"Blumenfeld","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1053\/j.ackd.2019.08.013_bib21","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","article-title":"Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide","volume":"46","author":"Houssiau","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1053\/j.ackd.2019.08.013_bib22","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1210\/endo.134.6.8194477","article-title":"Modulation of the expression of murine lupus by gonadotropin-releasing hormone analogs","volume":"134","author":"Jacobson","year":"1994","journal-title":"Endocrinology"},{"issue":"2","key":"10.1053\/j.ackd.2019.08.013_bib23","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/0006-291X(92)91322-H","article-title":"Human thymocytes secrete luteinizing hormone: an autocrine regulator of T-cell proliferation","volume":"187","author":"Sabharwal","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1053\/j.ackd.2019.08.013_bib24","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2215\/CJN.12441211","article-title":"Obstetric nephrology: lupus and lupus nephritis in pregnancy","volume":"7","author":"Stanhope","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2019.08.013_bib25","doi-asserted-by":"crossref","first-page":"355.e325","DOI":"10.1016\/j.amjmed.2005.08.045","article-title":"Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide","volume":"119","author":"Mok","year":"2006","journal-title":"Am J Med"},{"issue":"6","key":"10.1053\/j.ackd.2019.08.013_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies","volume":"62","author":"Park-Wyllie","year":"2000","journal-title":"Teratology"},{"issue":"6","key":"10.1053\/j.ackd.2019.08.013_bib27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1597\/02-077","article-title":"Maternal drug use and infant cleft lip\/palate with special reference to corticoids","volume":"40","author":"K\u00e4ll\u00e9n","year":"2003","journal-title":"Cleft Palate Craniofac J"},{"issue":"6","key":"10.1053\/j.ackd.2019.08.013_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/bdra.23248","article-title":"Corticosteroid use and risk of orofacial clefts","volume":"100","author":"Skuladottir","year":"2014","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"1","key":"10.1053\/j.ackd.2019.08.013_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/AOG.0000000000000905","article-title":"Protecting ovaries during chemotherapy through gonad suppression: a systematic review and meta-analysis","volume":"126","author":"Elgindy","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1053\/j.ackd.2019.08.013_bib30","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","article-title":"Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis","volume":"71","author":"Bertsias","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1053\/j.ackd.2019.08.013_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/0961203314555352","article-title":"Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus","volume":"24","author":"Koh","year":"2015","journal-title":"Lupus"},{"issue":"1","key":"10.1053\/j.ackd.2019.08.013_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0889-857X(05)70312-4","article-title":"Systemic lupus erythematosus flares during pregnancy","volume":"23","author":"Khamashta","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"10.1053\/j.ackd.2019.08.013_bib33","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1053\/j.ackd.2019.08.013_bib34","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1196\/annals.1361.105","article-title":"Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy","volume":"1051","author":"Ruiz-Irastorza","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"7651","key":"10.1053\/j.ackd.2019.08.013_bib35","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/bmj.39532.543947.BE","article-title":"Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review","volume":"336","author":"C\u00f4t\u00e9","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1053\/j.ackd.2019.08.013_bib36","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0002-9378(93)90043-I","article-title":"Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)","volume":"169","author":"Sibai","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.ackd.2019.08.013_bib37","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/1471-0528.12111","article-title":"Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review","volume":"120","author":"Piccoli","year":"2013","journal-title":"BJOG"},{"issue":"2","key":"10.1053\/j.ackd.2019.08.013_bib38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0961203314551812","article-title":"Renal biopsy in the management of lupus nephritis during pregnancy","volume":"24","author":"Chen","year":"2015","journal-title":"Lupus"},{"issue":"3","key":"10.1053\/j.ackd.2019.08.013_bib39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.ajkd.2013.06.002","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis","volume":"62","author":"Beck","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ackd.2019.08.013_bib40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejmg.2016.09.014","article-title":"Mycophenolate mofetil embryopathy: a newly recognized teratogenic syndrome","volume":"60","author":"Perez-Aytes","year":"2017","journal-title":"Eur J Med Genet"},{"issue":"8","key":"10.1053\/j.ackd.2019.08.013_bib41","first-page":"3016","article-title":"Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein","volume":"42","author":"Hales","year":"1982","journal-title":"Cancer Res"},{"issue":"4","key":"10.1053\/j.ackd.2019.08.013_bib42","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/ndt\/gfr484","article-title":"Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis","volume":"27","author":"Li","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ackd.2019.08.013_bib43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/j.ajkd.2010.08.036","article-title":"Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: a multicenter randomized clinical trial","volume":"57","author":"Chen","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ackd.2019.08.013_bib44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/ctr.12494","article-title":"The optimal therapy of calcineurin inhibitors for pregnancy in kidney transplantation","volume":"29","author":"Kim","year":"2015","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2019.08.013_bib45","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.34359","article-title":"Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study","volume":"64","author":"Rovin","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1053\/j.ackd.2019.08.013_bib46","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.38790","article-title":"Treatment of lupus nephritis with abatacept: the abatacept and cyclophosphamide combination efficacy and safety study","volume":"66","author":"Group","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1053\/j.ackd.2019.08.013_bib47","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis","volume":"64","author":"Hahn","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1053\/j.ackd.2019.08.013_bib48","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1053\/j.ackd.2019.08.013_bib49","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"},{"issue":"1","key":"10.1053\/j.ackd.2019.08.013_bib50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"10.1053\/j.ackd.2019.08.013_bib51","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"5","key":"10.1053\/j.ackd.2019.08.013_bib52","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1404595","article-title":"Less-tight versus tight control of hypertension in pregnancy","volume":"372","author":"Magee","year":"2015","journal-title":"N Engl J Med"},{"issue":"6461","key":"10.1053\/j.ackd.2019.08.013_bib53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bmj.290.6461.17","article-title":"Overview of randomised trials of diuretics in pregnancy","volume":"290","author":"Collins","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"2","key":"10.1053\/j.ackd.2019.08.013_bib54","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/HYPERTENSIONAHA.112.196352","article-title":"Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review","volume":"60","author":"Bullo","year":"2012","journal-title":"Hypertension"},{"key":"10.1053\/j.ackd.2019.08.013_bib55","doi-asserted-by":"crossref","first-page":"d5931","DOI":"10.1136\/bmj.d5931","article-title":"Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study","volume":"343","author":"Li","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1053\/j.ackd.2019.08.013_bib56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1081\/PRG-120002912","article-title":"Excretion of antihypertensive medication into human breast milk: a systematic review","volume":"21","author":"Beardmore","year":"2002","journal-title":"Hypertens Pregnancy"},{"issue":"5","key":"10.1053\/j.ackd.2019.08.013_bib57","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/0002-9378(95)90549-9","article-title":"Spironolactone therapy during human pregnancy","volume":"172","author":"Groves","year":"1995","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1053\/j.ackd.2019.08.013_bib58","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0950-3552(05)80332-3","article-title":"Pregnancy in women on haemodialysis and peritoneal dialysis","volume":"8","author":"Hou","year":"1994","journal-title":"Baillieres Clin Obstet Gynaecol"},{"issue":"5","key":"10.1053\/j.ackd.2019.08.013_bib59","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2013080825","article-title":"Intensive hemodialysis associates with improved pregnancy outcomes: a Canadian and United States cohort comparison","volume":"25","author":"Hladunewich","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2019.08.013_bib60","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0272-6386(98)70060-5","article-title":"Pregnancy and dialysis","volume":"31","author":"Bagon","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ackd.2019.08.013_bib61","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/ndt\/gfv395","article-title":"Pregnancy in dialysis patients in the new millennium: a systematic review and meta-regression analysis correlating dialysis schedules and pregnancy outcomes","volume":"31","author":"Piccoli","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1053\/j.ackd.2019.08.013_bib62","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/ki.2009.48","article-title":"The importance of low blood urea nitrogen levels in pregnant patients undergoing hemodialysis to optimize birth weight and gestational age","volume":"75","author":"Asamiya","year":"2009","journal-title":"Kidney Int"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559519301533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559519301533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:01:27Z","timestamp":1761548487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559519301533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1548559519301533"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2019.08.013","relation":{},"ISSN":["1548-5595"],"issn-type":[{"type":"print","value":"1548-5595"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy in Women With Systemic Lupus and Lupus Nephritis","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2019.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}